Skip to main content

Table 2 Secondary endpoints

From: A randomized controlled trial to investigate the influence of low dose radiotherapy on immune stimulatory effects in liver metastases of colorectal cancer

Secondary endpoints

• Local control and recurrence patterns of colorectal liver metastasis

• Progression free survival

• Surgical morbidity in patients undergoing liver resection who received this protocol treatment

• 30 day postoperative mortality

• Radiation toxicity

• Quality of life according to EORTC QoL questionnaire after 3 and 6 months